138 related articles for article (PubMed ID: 31496500)
1. Clinical Use Cases for a Tool to Assess Risk in Superficial Bladder Cancer.
McMullen CK; Rosetti MO; Weinmann S; Leo MC; Nielsen ME
Perm J; 2019; 23():. PubMed ID: 31496500
[TBL] [Abstract][Full Text] [Related]
2. Contemporary management of superficial bladder cancer in the United States: a pattern of care analysis.
Joudi FN; Smith BJ; O'Donnell MA; Konety BR
Urology; 2003 Dec; 62(6):1083-8. PubMed ID: 14665360
[TBL] [Abstract][Full Text] [Related]
3. To oophorectomy or not to oophorectomy: Practice patterns among urologists treating bladder cancer.
Sussman RD; Han CJ; Marchalik D; Carvahlo FL; Davis MF; Richter LA; Wethington SL; Stamatakis L
Urol Oncol; 2018 Mar; 36(3):90.e1-90.e7. PubMed ID: 29273351
[TBL] [Abstract][Full Text] [Related]
4. [Observational survey of the French Urological Association Oncology Committee (CCAFU) evaluating the practice of immediate postoperative instillation (IPOP) using mitomycin C for non-muscle invasive bladder cancer (NMIBC) treatment].
Neuzillet Y; Colin P; Comperat E; Dubosq F; Houede N; Larre S; Masson-Lecomte A; Pignot G; Puech P; Roumiguie M; Xylinas E; Mejean A; Roupret M
Prog Urol; 2016 Mar; 26(3):181-90. PubMed ID: 26777686
[TBL] [Abstract][Full Text] [Related]
5. Urological surveillance and management of patients with neurogenic bladder: Results of a survey among practicing urologists in Canada.
Blok BF; Karsenty G; Corcos J
Can J Urol; 2006 Oct; 13(5):3239-43. PubMed ID: 17076944
[TBL] [Abstract][Full Text] [Related]
6. Current practice in the management of superficial bladder cancer in the Netherlands and Belgian Flanders: a survey.
Witjes JA; Melissen DO; Kiemeney LA
Eur Urol; 2006 Mar; 49(3):478-84. PubMed ID: 16406242
[TBL] [Abstract][Full Text] [Related]
7. Bladder-sparing Radiotherapy for Muscle-invasive Bladder Cancer: A Qualitative Study to Identify Barriers and Enablers.
Walker M; Doiron RC; French SD; Feldman-Stewart D; Siemens DR; Mackillop WJ; Booth CM
Clin Oncol (R Coll Radiol); 2017 Dec; 29(12):818-826. PubMed ID: 28951003
[TBL] [Abstract][Full Text] [Related]
8. Bladder-sparing radiotherapy for muscle-invasive bladder cancer: A survey of providers to determine barriers and enablers.
Walker M; French SD; Doiron RC; Brennan K; Feldman-Stewart D; Siemens DR; Mackillop WJ; Booth CM
Radiother Oncol; 2017 Nov; 125(2):351-356. PubMed ID: 28974310
[TBL] [Abstract][Full Text] [Related]
9. Can urologists accurately stage and grade urothelial bladder cancer by assessing endoscopic photographs?
Dekalo S; Matzkin H; Mabjeesh NJ
J Telemed Telecare; 2018 Oct; 24(9):603-607. PubMed ID: 28920525
[TBL] [Abstract][Full Text] [Related]
10. Are we following the guidelines on non-muscle invasive bladder cancer?
Reis LO; Moro JC; Ribeiro LF; Voris BR; Sadi MV
Int Braz J Urol; 2016; 42(1):22-8. PubMed ID: 27136464
[TBL] [Abstract][Full Text] [Related]
11. Surgical checklist impact on recurrence-free survival of patients with non-muscle-invasive bladder cancer undergoing transurethral resection of bladder tumour.
Suarez-Ibarrola R; Soria F; Abufaraj M; D'Andrea D; Preto M; Gust KM; Briganti A; Shariat SF; Gontero P
BJU Int; 2019 Apr; 123(4):646-650. PubMed ID: 30248235
[TBL] [Abstract][Full Text] [Related]
12. Differences between urologists in United States and Canada in approach to bladder cancer.
Chung D; Hersey K; Fleshner N
Urology; 2005 May; 65(5):919-25. PubMed ID: 15882724
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of nonlinear optimization for scheduling of follow-up cystoscopies to detect recurrent bladder cancer. The Bladder Cancer follow-up Group.
Kent DL; Nease RA; Sox HC; Shortliffe LD; Shachter R
Med Decis Making; 1991; 11(4):240-8. PubMed ID: 1662739
[TBL] [Abstract][Full Text] [Related]
14. [Intravesical adjuvant chemotherapy for superficial bladder cancer -- results of a survey in Saxony].
Steinbach F; Schuster F
Aktuelle Urol; 2005 Aug; 36(4):337-41. PubMed ID: 16110407
[TBL] [Abstract][Full Text] [Related]
15. British Association of Paediatric Urologists consensus statement on the management of the neuropathic bladder.
Lee B; Featherstone N; Nagappan P; McCarthy L; O'Toole S
J Pediatr Urol; 2016 Apr; 12(2):76-87. PubMed ID: 26946946
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the Current Place of Radiotherapy as Treatment Option for Patients With Muscle Invasive Bladder Cancer in Belgium.
Fonteyne V; Rammant E; Ost P; Lievens Y; De Troyer B; Rottey S; De Meerleer G; De Maeseneer D; De Ridder D; Decaestecker K
Clin Genitourin Cancer; 2018 Dec; 16(6):e1159-e1169. PubMed ID: 30190222
[TBL] [Abstract][Full Text] [Related]
17. Current practice patterns in urologic management of upper-tract transitional-cell carcinoma.
Razdan S; Johannes J; Cox M; Bagley DH
J Endourol; 2005 Apr; 19(3):366-71. PubMed ID: 15865529
[TBL] [Abstract][Full Text] [Related]
18. [Highlighting differences in the management of neurogenic bladder existing between urologists and physiatrists: A survey conducted among 383 specialists].
Denys P; Soler JM; Fatton B; Rischmann P; Yelnik A; Aegerter P; Saidji-Domingo NY; Chartier-Kastler E
Presse Med; 2012 Dec; 41(12 Pt 1):e599-608. PubMed ID: 22633051
[TBL] [Abstract][Full Text] [Related]
19. Relationship Between Availability of Urologists and Primary Care Providers and Stage of Diagnosis for Invasive Urinary Bladder Cancer.
Segel JE; Wong WG; Kaag M; Joshi M; Warrick J; Lengerich EJ; Shen C
Urol Pract; 2024 Mar; 11(2):339-346. PubMed ID: 38305777
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence diagnosis and flat lesions of urothelium: new challenges for pathologists and urologists (Review).
Compérat E; Conort P; Roupret M; Capron F; Camparo P; Montironi R
Oncol Rep; 2009 Apr; 21(4):839-44. PubMed ID: 19287977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
